Variant-targeted COVID-19 boosters test the promise of mRNA technology

Drew Weissman of the Perelman School of Medicine, whose key discoveries about mRNA contributed to Moderna and BioNTech, says that mRNA is designed to rapidly adapt to new strains and variants of virus.

・ From The Wall Street Journal